In diabetes, some statins reduce non-HDL-C better than others vs. placebo.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 35914251.
- Also identified by DOI 10.7326/J22-0051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hodkinson A, Tsimpida D, Kontopantelis E, et al. <b>Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.</b> BMJ. 2022;376:e067731. 35331984.
Medical subject headings
- Cardiovascular Diseases
- Diabetes Mellitus
- Hydroxymethylglutaryl-CoA Reductase Inhibitors